Pavel Ryšánek

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Topics

Clinical Evaluation

Pseudomonas Aeruginosa

Top Venues

British journal of pharmacology

Pharmaceutical research

This page only lists publications with an associated author ORCID identifier.

Publications

Jiří Hofmann, Aleš Bartůněk, Tomáš Hauser, Gregor Sedmak, Josef Beránek, Pavel Ryšánek, Martin Sima, Ondrej Slanar
Dasatinib anhydrate containing oral formulation improves variability and bioavailability in humans. Leukemia (2023)
Jana Královičová, Aleš Bartůněk, Jiří Hofmann, Tomáš Křížek, Petr Kozlík, Jaroslava Roušarová, Pavel Ryšánek, Martin Sima, Ondrej Slanar
Pharmacokinetic Variability in Pre-Clinical Studies: Sample Study with Abiraterone in Rats and Implications for Short-Term Comparative Pharmacokinetic Study Designs. Pharmaceutics 14 (3) (2022)
Martin Sima, Daniel Bobek, Petra Cihlářová, Pavel Ryšánek, Jaroslava Roušarová, Jan Beroušek, Martin Kuchar, Tomáš Vymazal, Ondrej Slanar
Factors Affecting the Metabolic Conversion of Ciprofloxacin and Exposure to Its Main Active Metabolites in Critically Ill Patients: Population Pharmacokinetic Analysis of Desethylene Ciprofloxacin. Pharmaceutics 14 (8) (2022)
Pavel Ryšánek, Tomáš Grus, Peter Lukáč, Petr Kozlík, Tomáš Křížek, Jiří Pozniak, Jaroslava Roušarová, Jana Královičová, Nikolina Kutinová Canová, Tereza Boleslavská, Jan Bosák, František Štěpánek, Martin Sima, Ondřej Slanař
Validity of cycloheximide chylomicron flow blocking method for the evaluation of lymphatic transport of drugs. British journal of pharmacology 178 (23) (2021)
Martin Sima, Danica Michaličková, Pavel Ryšánek, Petra Cihlářová, Martin Kuchař, Daniela Lžičařová, Jan Beroušek, Jan Miroslav Hartinger, Tomáš Vymazal, Ondřej Slanař
No Time Dependence of Ciprofloxacin Pharmacokinetics in Critically Ill Adults: Comparison of Individual and Population Analyses. Pharmaceutics 13 (8) (2021)
Pavel Ryšánek, Tomáš Grus, Martin Šíma, Ondřej Slanař
Lymphatic Transport of Drugs after Intestinal Absorption: Impact of Drug Formulation and Physicochemical Properties. Pharmaceutical research 37 (9) (2020)